Why Attendees Value the CAR-TCR Summit
“I value the CAR-TCR Summit as a focused meeting that keeps up-to-date with the most pressing challenges and opportunities in our field.”
Shon Green, Chief Scientific Officer, Zelig Therapeutics, 2026 Speaker
“The CAR-TCR Summit is the key event of the year to meet all relevant industry and academic stakeholders in the field of T-cell therapies against cancer and autoimmune diseases.”
Felix Lorenz, Chief Executive Officer & Chief Scientific Officer, Captain T Cell, 2026 Speaker
“The CAR-TCR Summit brings together like-minded teams from around the World to share critical findings and learnings towards continued improvements in patient benefits and I want to contribute to that endeavour.”
Mark Exley, Chief Scientific Officer, LIfT Biosciences, 2026 Speaker
“I’m looking forward to learning more about the latest strategies being deployed to combat solid tumors with cell therapies.”
Mark Wallet, Chief Scientific Officer, LinkCell Therapies, 2026 Speaker
“I look forward to joining colleagues across the cell therapy community to discuss how advances in manufacturing, automation, and governance can support the reliable and scalable delivery of CAR-T therapies to patients.”
Jose Caraballo, Vice President, Quality Compliance, Kite Pharma, 2026 Speaker
“I’m looking forward to connecting with peers to discuss how CAR and TCR innovations are shaping the cell therapy landscape, exchanging perspectives on how clinical development, scalability and commercialization can be optimized to improve patient access and engaging in forward-looking discussions on the next phase of innovation.”
Serena De Vita, Vice President, Global Franchise Head & Clinical Strategy Head, Late Development Oncology, Cell Therapy, ORD, AstraZeneca, 2026 Speaker
“I am looking forward to sharing information on the unmatched potential of Precigen’s UltraCAR-T platform and engaging with leaders across the industry on how next-generation cell therapies can deliver more durable, accessible, and scalable treatment options for patients.”
Dr. Helen Sabzevari, President & Chief Executive Officer, Precigen, 2026 Speaker
“I’m excited to engage across the full cell therapy ecosystem and learn how emerging clinical data, engineering advances, and manufacturing innovations can converge to deliver durable, scalable impact for patients.”
Bruce Levine, Barbara & Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania, 2026 Speaker
“This is such an important moment for the cell therapy field as we continue to move more programs toward pivotal and commercial readiness. I’m looking forward to learning from peers across the industry about how teams are refining CQAs, strengthening control strategies, and making practical, science-based decisions that protect product quality while preserving the flexibility needed during development. Most importantly, I’m excited to exchange ideas on how we can keep patient safety at the center of these decisions.”
Emily Lowe, Director, Product Analytical Science, Astrazeneca, 2026 Speaker
“As a repeating attendee of CAR-TCR, I look forward to returning each year. The conference is the right mix of information, data, networking, and frank exchanges.”
Senior Vice President, Process, Analytical Development & Clinical Manufacturing, 2seventy bio, Past Attendee
“My experience at this international conference was truly enriching and memorable. What made it so enjoyable was the opportunity to connect with professionals from around the world who share my passion for cell therapy.”
Scientist, Chugai Pharma, Past Attendee
“The conference covered broad range of topics that are essential for new CAR and TCR therapeutic drug development. I particularly enjoyed the discussions on late stage, regulatory aspects, and the overall landscape review.”
Principal Scientist, Cabaletta Bio, Past Attendee
“The amount of external vendors showcasing their advances in equipment and platform capabilities was very impressive and allowed for a lot of great discussions about potential new collaborations.”
Associate Director, Kiragen Bio, Past Sponsor
“A wide range of areas of expertise from discovery/clinical though early and late stage manufacturing allowed one to get a sense of where the CAR-T and TCR fields are currently and where they are heading.”
Senior Associate, Kyowa Kirin, Past Sponsor
“I enjoyed the strong networking sessions & lots of time and opportunities to connect. There were also great number of decision makers in attendance.”
Director, Vector Biomed, Past Sponsor
Explore the Agenda
Get a front row seat to the latest cell therapy breakthroughs across autoimmune disease, solid tumors and novel modalities through data-driven technical presentations, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of cell therapy deals.
Join Biopharma Experts
Be part of the hottest conversations in this tailor-made forum for senior executives across all stages of CAR and TCR drug development and make critical connections during our dedicated networking sessions and CAR-TCR Connect drinks reception.